Keros Therapeutics Inc. (KROS)
undefined
undefined%
At close: undefined
18.64
-1.01%
After-hours Dec 13, 2024, 07:59 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 151.00K - 20.10M - 10.00M 10.00M
Cost of Revenue 815.00K 1.61M 898.00K 605.00K 17.35M 10.11M
Gross Profit -664.00K -1.61M 19.20M -605.00K -7.35M -111.00K
Operating Income -169.94M -114.79M -56.37M -46.66M -10.56M -1.69M
Interest Income - 1K 4.00K 6.00K 8.00K 6.00K
Pretax Income -152.99M -104.68M -56.73M -45.53M -12.34M -1.08M
Net Income -152.99M -104.68M -58.74M -45.36M -12.34M -1.33M
Selling & General & Admin 34.83M 27.52M 21.33M 12.80M 3.18M 1.58M
Research & Development 135.26M 87.27M 55.14M 33.86M 17.38M 10.11M
Other Expenses - -7.08M -356.00K -2.46M -558.00K 237.00K
Operating Expenses 170.09M 107.71M 76.47M 44.20M 20.00M 11.32M
Interest Expense - 1K 4.00K 6.00K 8.00K -
Selling & Marketing Expenses - - - - - -
Cost & Expenses 170.09M 107.71M 76.47M 44.20M 20.00M 11.32M
Income Tax - 1K 2.01M -172.00K 8.00K 257.00K
Shares Outstanding (Basic) 29.45M 25.24M 23.33M 15.51M 8.88M 8.88M
Shares Outstanding (Diluted) 29.45M 25.24M 23.33M 15.51M 8.88M 8.88M
EPS (Basic) -5.2 -4.15 -2.52 -2.93 -1.39 -0.15
EPS (Diluted) -5.2 -4.15 -2.52 -2.93 -1.39 -0.15
EBITDA -152.18M -103.06M -56.37M -44.92M -11.89M -774.00K
Depreciation & Amortization 815.00K 1.61M 898.00K 605.00K 438.00K 304.00K